LabID-base/OpenAlex-Afillation huggingface dataset:
TRIPLE COMBINATION THERAPY IN THE FIRST-LINE TREATMENT OF SOFT TISSUE SARCOMA WITH HIGH TUMOR BURDEN: UPDATE ANALYSIS OF THE DDLPS COHORT AND BIOMARKERS
Year: 2025
Type: article
Language: en
Topic: Sarcoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: Y.U.H.O.N.G. ZHOU
raw_affiliation_strings: Department of Medical Oncology, Zhongshan Hospital, Fudan University, SHANGHAI, Shanghai, China (People's Republic)
raw_author_name: Wei Li
raw_affiliation_strings: Department of Medical Oncology, Zhongshan Hospital, Fudan University,Shanghai, China, Shanghai, Shanghai, China (People's Republic)
raw_author_name: Meiyu Fang
raw_affiliation_strings: Rare Cancer & Head and Neck Medical Oncology, Zhejiang Cancer Hospital - Cancer Research Institute, Hangzhou, Zhejiang, China (People's Republic)
raw_author_name: Rongyuan Zhuang
raw_affiliation_strings: Department of Medical Oncology, Zhongshan Hospital, Fudan University,Shanghai, China, Shanghai, Shanghai, China (People's Republic)
raw_author_name: Yi Feng
raw_affiliation_strings: Department of Medical Oncology, Zhongshan Hospital, Fudan University,Shanghai, China, Shanghai, Shanghai, China (People's Republic)
raw_author_name: Xi Guo
raw_affiliation_strings: Department of Medical Oncology, Zhongshan Hospital, Fudan University,Shanghai, China, Shanghai, Shanghai, China (People's Republic)
raw_author_name: Chenlu Zhang
raw_affiliation_strings: Department of Medical Oncology, Zhongshan Hospital, Fudan University,Shanghai, China, Shanghai, Shanghai, China (People's Republic)
raw_author_name: Yuqin Ding
raw_affiliation_strings: Zhongshan Hospital, Fudan University,Shanghai, China, Shanghai, Shanghai, China (People's Republic)
raw_author_name: Rongkui Luo
raw_affiliation_strings: Zhongshan Hospital, Fudan University,Shanghai, China, Shanghai, Shanghai, China (People's Republic)
raw_author_name: Zhiming Wang
raw_affiliation_strings: Zhongshan Hospital, Fudan University,Shanghai, China, Shanghai, Shanghai, China (People's Republic)
raw_author_name: Zhengfu Fan
raw_affiliation_strings: Beijing Cancer Hospital, Shanghai, Shanghai, China (People's Republic)
raw_author_name: Hanxing Tong
raw_affiliation_strings: Zhongshan Hospital, Fudan University,Shanghai, China, Shanghai, Shanghai, China (People's Republic)
raw_author_name: Yong Zhang
raw_affiliation_strings: Zhongshan Hospital, Fudan University,Shanghai, China, Shanghai, Shanghai, China (People's Republic)
raw_author_name: Weiqi Lu
raw_affiliation_strings: Department of Surgical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China, Shanghai, Shanghai, China (People's Republic)
raw_author_name: Weitao Yao
raw_affiliation_strings: Boneand Soft Tissue Department, Henan Cancer Hospital/Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China (People's Republic)
TARGETING CANCER STEM CELLS AND THERAPY-INDUCED SENESCENT CELLS IN CHORDOMA
Year: 2025
Type: article
Language: en
Topic: Cancer Cells and Metastasis
Authors and affiliations:
raw_author_name: Xinhui Wang
raw_affiliation_strings: Massachusetts General Hospital, bOSTON, MA
raw_author_name: Feng Chen
raw_affiliation_strings: Massachusetts General Hospital, Boston, MA
raw_author_name: Edwin Choy
raw_affiliation_strings: Mass General Cancer Center, Massachusetts General Hospital, Boston, MA
raw_author_name: Ananthan Sadagopan
raw_affiliation_strings: Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Boston, MA
raw_author_name: Yen-Lin E. Chen
raw_affiliation_strings: Radiation Oncology, Massachusetts General Hospital, Boston, MA
raw_author_name: Joseph H. Schwab
raw_affiliation_strings: Cedars-Sinai Medical Center, Orthopedic Surgery, Los Angeles, CA
raw_author_name: Daniel G. Tobert
raw_affiliation_strings: Orthopaedic Oncology, Massachusetts General Hospital, Boston, MA
MULTI-OMIC ANALYSIS OF 1001 GIST TUMORS REVEALS IMMUNE ENRICHED SUBTYPES
Year: 2025
Type: article
Language: en
Topic: Gastrointestinal Tumor Research and Treatment
Authors and affiliations:
raw_author_name: Nathan D. Seligson
raw_affiliation_strings: University of Florida, Jacksonville, FL
raw_author_name: Nathan D. Maulding
raw_affiliation_strings: Tempus AI, Inc., Chicago, IL
raw_author_name: Andrew J. Sedgewick
raw_affiliation_strings: Tempus AI, Inc., Chicago, IL
raw_author_name: Danielle E. Hamel
raw_affiliation_strings: Tempus AI, Inc., Chicago, IL
raw_author_name: Jason K. Sicklick
raw_affiliation_strings: Dept. of Surgery, Moores Cancer Center, University of California San Diego, San Diego, CA
raw_author_name: James L. Chen
raw_affiliation_strings: Tempus AI, Inc., Chicago, IL
PARANEOPLASTIC SYNDROME AND CACHEXIA-RELATED CYTOKINES IN DEDIFFERENTIATED LIPOSARCOMA (DDLPS) OF THE RETROPERITONEUM
Year: 2025
Type: article
Language: en
Topic: Nutrition and Health in Aging
Authors and affiliations:
raw_author_name: Marco Fiore
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, Italy
raw_author_name: Sandro Pasquali
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy
raw_author_name: Sara Iadecola
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy
raw_author_name: Valentina Zuco
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy
raw_author_name: Valentina Guido
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy
raw_author_name: Roberta Sanfilippo
raw_affiliation_strings: Fondazione IRCCS Istituto nazionale dei tumori, Milan, Lombardia, Italy
raw_author_name: Dario Callegaro
raw_affiliation_strings: Fondazione IRCCS IStituto Nazionale dei Tumori, Milan, Italy, Milan, Lombardia, Italy
raw_author_name: Alessandro Delcarro
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy
raw_author_name: Silvia Stacchiotti
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy
raw_author_name: Chiara Colombo
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy
raw_author_name: Stefano Radaelli
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy
raw_author_name: Marco Baia
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy
raw_author_name: Rossella Bertulli
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy
raw_author_name: Laura Cattaneo
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy
raw_author_name: Daniele Morelli
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy
raw_author_name: Rosalba Miceli
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Milano, Lombardia, Italy
raw_author_name: Alessandro Gronchi
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Milano, Lombardia, Italy
ASSOCIATION OF CLINICO-PATHOLOGIC FEATURES AND MOLECULAR GENOTYPES WITH OUTCOMES OF SYSTEMIC THERAPY IN METASTATIC SOFT TISSUE LEIOMYOSARCOMA (LMS) PATIENTS
Year: 2025
Type: article
Language: en
Topic: Sarcoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: Robert G. MAKI
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY
raw_author_name: Josephine K. Dermawan
raw_affiliation_strings: Cleveland Clinic, Cleveland, OH
raw_author_name: Sujana Movva
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, NY
raw_author_name: Sandra P. D'Angelo
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, NY
raw_author_name: Ciara M. Kelly
raw_affiliation_strings: Sarcoma Medical Oncology Service, Memorial Sloan Kettering, New York, NY
raw_author_name: Viswatej Avutu
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, NY
raw_author_name: Lauren Banks
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, NY
raw_author_name: Jason E. Chan
raw_affiliation_strings: Memorial Sloan-Kettering Cancer Center, Weill-Cornell Medical College, NEW YORK, NY
raw_author_name: Ping Chi
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, NY
raw_author_name: Mark A. Dickson
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, NY
raw_author_name: Mrinal M. Gounder
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY
raw_author_name: Mary Keohan
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, NY
raw_author_name: Evan Rosenbaum
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, NY
raw_author_name: Damon Reed
raw_affiliation_strings: Memorial Sloan Kettering, New York, NY
raw_author_name: Alyssa Cermele
raw_affiliation_strings: Memorial Sloan-Kettering Cancer Center, NEW YORK, NY
raw_author_name: William D. Tap
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, NY
raw_author_name: Cristina R. Antonescu
raw_affiliation_strings: Memorial Sloan-Kettering Cancer Center, Weill-Cornell Medical College, New York, NY
IMMUNOSARC2 (COHORT 7A): A SPANISH SARCOMA GROUP (GEIS) PHASE IB TRIAL OF EPIRUBICIN AND IFOSFAMIDE PLUS NIVOLUMAB IN FIRST LINE OF ADVANCED UNDIFFERENTIATED PLEOMORPHIC SARCOMA (UPS)
Year: 2025
Type: article
Language: en
Topic: Multiple Myeloma Research and Treatments
Authors and affiliations:
raw_author_name: Javier Martín-Broto
raw_affiliation_strings: Fundación Jiménez Díaz University Hospital, Madrid, Madrid, Spain
raw_author_name: Javier Martinez-Trufero
raw_affiliation_strings: Hospital Universitario Miguel Servet, Zaragoza, Aragon, Spain
raw_author_name: Robertodiaz Beveridge
raw_affiliation_strings: HU LA FE, VALENCIA, Comunidad Valenciana, Spain
raw_author_name: Irenecarrasco Garcia
raw_affiliation_strings: HU VIRGEN DEL ROCIO, SEVILLE, Andalucia, Spain
raw_author_name: David S. da Silva Moura
raw_affiliation_strings: INSTITUTO DE INVESTIGACIÓN SANITARIA FUNDACIÓN JIMENEZ DIAZ (IIS-FJD), MADRID, Madrid, Spain
raw_author_name: Ana Sebio García
raw_affiliation_strings: Hospital de la Santa Creu i Sant Pau, IR Sant Pau, Barcelona, Catalonia, Spain
raw_author_name: Enriquegonzalez Billalabeitia
raw_affiliation_strings: HU DOCE DE OCTUBRE, MADRID, Madrid, Spain
raw_author_name: Rafaelramos Asensio
raw_affiliation_strings: Hospital Quirón Palmaplanas, PALMA, Islas Baleares, Spain
raw_author_name: Antonio Gutierrez
raw_affiliation_strings: HU SON ESPASES, PALMA, Islas Baleares, Spain
raw_author_name: Josefina Cruz
raw_affiliation_strings: HU CANARIAS, TENERIFE, Canarias, Spain
raw_author_name: Claudia Valverde
raw_affiliation_strings: HU VALL D'HEBRON, BARCELONA, Catalonia, Spain
raw_author_name: Patricio Ledesma
raw_affiliation_strings: SOFPROMED, PALMA, Islas Baleares, Spain
raw_author_name: Nadia Hindi
raw_affiliation_strings: Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Madrid, Spain
PROGNOSTIC AND BIOLOGIC SIGNIFICANCE OF ATRX MUTATION IN ADULT SOFT TISSUE SARCOMA
Year: 2025
Type: article
Language: en
Topic: Telomeres, Telomerase, and Senescence
Authors and affiliations:
raw_author_name: Anand Singh
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Yingda Jiang
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Zhao Zheng
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Davis R. Ingram
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Khalida M. Wani
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Veena Kochat
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Sharon M. Landers
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Angela D. Bhalla
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: William Padron
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Yiming Cai
raw_affiliation_strings: The University of Texas MD Anderson Cancer Center, Houston, TX
raw_author_name: Haoqiang Ying
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Heather Lin
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Jason Huse
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Emily Z. Keung
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Wei-Lien Wang
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Ahsan Farooqi
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Anthony P. Conley
raw_affiliation_strings: University of Texas MD Anderson Cancer Center, Houston, TX
raw_author_name: Shreyaskumar Patel
raw_affiliation_strings: University of Texas MD Anderson Cancer Center, Houston, TX
raw_author_name: Neeta Somaiah
raw_affiliation_strings: Department of Sarcoma Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX
raw_author_name: Alexander J. Lazar
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Elise F. Nassif Haddad
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Keila E. Torres
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Kunal Rai
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Ryan A. Denu
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
CIRCULATING TUMOR DNA IN PATIENTS WITH INTERMEDIATE RISK RHABDOMYOSARCOMA ON ARST1431: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Year: 2025
Type: article
Language: en
Topic: Cancer Genomics and Diagnostics
Authors and affiliations:
raw_author_name: Natalie B. Collins
raw_affiliation_strings: Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
raw_author_name: Kelly Klega
raw_affiliation_strings: Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
raw_author_name: Wei Xue
raw_affiliation_strings: COG Data Center, Gainesville, FL
raw_author_name: Zhengya Gao
raw_affiliation_strings: COG Data Center, Gainesville, FL
raw_author_name: David S. Shulman
raw_affiliation_strings: Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
raw_author_name: Mohammad Tanhaemami
raw_affiliation_strings: Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
raw_author_name: Catherine Clinton
raw_affiliation_strings: Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
raw_author_name: Julia Schiantarelli
raw_affiliation_strings: Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
raw_author_name: Samuel Abbou
raw_affiliation_strings: Gustave Roussy, Paris, Ile-de-France, France
raw_author_name: Douglas J. Harrison
raw_affiliation_strings: Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX
raw_author_name: Abha A. Gupta
raw_affiliation_strings: The Hospital for Sick Children and Princess Margaret Cancer Center, Toronto, ON, Canada, Toronto, ON, Canada
raw_author_name: Raj Venkatramani
raw_affiliation_strings: Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX
raw_author_name: Brian D. Crompton
raw_affiliation_strings: Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
DISSECTING TUMOR HETEROGENEITY AND CELL STATE-SPECIFIC THERAPEUTIC TARGETS FROM SINGLE-NUCLEI RNA-SEQ OF CIC::DUX4 ROUND CELL SARCOMA
Year: 2025
Type: article
Language: en
Topic: Sarcoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: Carla Saoud
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, NEW YORK CITY, NY
raw_author_name: Filemon S. Dela Cruz
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, NY
raw_author_name: Damon Reed
raw_affiliation_strings: Memorial Sloan Kettering, New York, NY
raw_author_name: Alice Soragni
raw_affiliation_strings: UCLA, Los Angeles, CA
raw_author_name: Yuen Bun Tam
raw_affiliation_strings: The Institute of Cancer Research (ICR), London, London, England, United Kingdom
raw_author_name: Paul Huang
raw_affiliation_strings: ICR London, London, England, United Kingdom
raw_author_name: Jovana Pavisic
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, NY
raw_author_name: Cristina R. Antonescu
raw_affiliation_strings: Memorial Sloan-Kettering Cancer Center, Weill-Cornell Medical College, New York, NY
raw_author_name: Fabio Vanoli
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, NY
THE IMPACT OF WHOLE-LUNG IRRADIATION ON SURVIVAL IN ADULTS WITH SMALL ROUND CELL SARCOMAS
Year: 2025
Type: article
Language: en
Topic: Transplantation: Methods and Outcomes
Authors and affiliations:
raw_author_name: Aneta W. Borkowska
raw_affiliation_strings: Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Mazowieckie, Poland
raw_author_name: Paulina Chmiel
raw_affiliation_strings: Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Mazowieckie, Poland
raw_author_name: Paulina Jagodzinska-Mucha
raw_affiliation_strings: Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Mazowieckie, Poland
raw_author_name: Piotr Rutkowski
raw_affiliation_strings: Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Mazowieckie, Poland
raw_author_name: Mateusz J. Spalek
raw_affiliation_strings: Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Mazowieckie, Poland
SAFETY AND EARLY EFFICACY OF VT3989, A TEAD INHIBITOR, IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): A PHASE I/II STUDY
Year: 2025
Type: article
Language: en
Topic: Myasthenia Gravis and Thymoma
Authors and affiliations:
raw_author_name: Candace L. Haddox
raw_affiliation_strings: Dana Farber Cancer Institute, Boston, MA
raw_author_name: Mrinal M. Gounder
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY
raw_author_name: Timothy A. Yap
raw_affiliation_strings: MD Anderson Cancer Center, Houston, TX
raw_author_name: Michael Offin
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, NY
raw_author_name: David J. Kwiatkowski
raw_affiliation_strings: Dana Farber Cancer Institute, Boston, MA
raw_author_name: Robert Kratzke
raw_affiliation_strings: University of Minnesota Masonic Cancer Center, Minneapolis, MN
raw_author_name: Ibiayi Dagogo-Jack
raw_affiliation_strings: Massachusetts General Hospital, Boston, MA
raw_author_name: Anthony W. Tolcher
raw_affiliation_strings: NEXT Oncology, San Antonio, TX
raw_author_name: Jayesh Desai
raw_affiliation_strings: Peter MacCallum Cancer Center, Melbourne, Victoria, Australia
raw_author_name: Amy L. Body
raw_affiliation_strings: Monash Medical Centre, Melbourne, Victoria, Australia
raw_author_name: Michael Millward
raw_affiliation_strings: Linear Clinical Research, Nedlands, Western Australia, Australia
raw_author_name: Hedy L. Kindler
raw_affiliation_strings: The University of Chicago Medicine, Chicago, IL
raw_author_name: Tracy T. Tang
raw_affiliation_strings: Vivace Therapeutics, San Mateo, CA
raw_author_name: Yufeng Li
raw_affiliation_strings: Vivace, San Mateo, CA
raw_author_name: Neelesh Sharma
raw_affiliation_strings: Vivace Therapeutics, Livingston, NJ
raw_author_name: Gregory M. Cote
raw_affiliation_strings: Mass General Cancer Center, Massachusetts General Hospital, Boston, MA
IMPROVED POST-RELAPSE SURVIVAL OVER TIME IN RECURRENT RETROPERITONEAL SOFT TISSUE SARCOMA: AN AI-BASED DIGITAL TWIN COUNTERFACTUAL ANALYSIS
Year: 2025
Type: article
Language: en
Topic: Sarcoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: Roberta Sanfilippo
raw_affiliation_strings: Fondazione IRCCS Istituto nazionale dei tumori, Milan, Lombardia, Italy
raw_author_name: Andrea Franza
raw_affiliation_strings: Fondazione IRCCS Istituto nazionale dei tumori, Milan, Lombardia, Italy
raw_author_name: Gabriele Tinè
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Mialno, Milan, Lombardia, Italy
raw_author_name: Chiara Fabbroni
raw_affiliation_strings: Fondazione IRCCS Istituto nazionale dei tumori, Milan, Lombardia, Italy
raw_author_name: Dario Callegaro
raw_affiliation_strings: Fondazione IRCCS IStituto Nazionale dei Tumori, Milan, Italy, Milan, Lombardia, Italy
raw_author_name: Carlo Morosi
raw_affiliation_strings: Fondazione IRCCS Istituto nazionale dei tumori, Milan, Lombardia, Italy
raw_author_name: Paola Collini
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Milano, Lombardia, Italy
raw_author_name: Andrea Vanzulli
raw_affiliation_strings: Fondazione IRCCS Istituto nazionale dei tumori, Milan, Lombardia, Italy
raw_author_name: Claudia Sangalli
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Milano, Lombardia, Italy
raw_author_name: Elena R. Fumagalli
raw_affiliation_strings: Fondazione IRCCS Istituto nazionale dei tumori, Milan, Lombardia, Italy
raw_author_name: Pierluigi Di Mauro
raw_affiliation_strings: Fondazione IRCCS Istituto nazionale dei tumori, Milan, Lombardia, Italy
raw_author_name: Gabriella Greco
raw_affiliation_strings: Fondazione IRCCS Istituto nazionale dei tumori, milan, Lombardia, Italy
raw_author_name: Marco Fiore
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Lombardia, Italy
raw_author_name: Silvia Stacchiotti
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia, Italy
raw_author_name: Paolo G. Casali
raw_affiliation_strings: Fondazione IRCCS Istituto nazionale dei tumori, Milan, Lombardia, Italy
raw_author_name: Rosalba Miceli
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Milano, Lombardia, Italy
raw_author_name: Alessandro Gronchi
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Milano, Lombardia, Italy
PREOPERATIVE RADIOTHERAPY AND POSTOPERATIVE COMPLICATIONS AMONG PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA: A POST HOC ANALYSIS OF THE EORTC-62092 (STRASS) PHASE 3 RANDOMIZED CLINICAL TRIAL
Year: 2025
Type: article
Language: en
Topic: Sarcoma Diagnosis and Treatment
Authors and affiliations:
raw_author_name: Fabio Tirotta
raw_affiliation_strings: University Hospitals Birmingham NHS Foundation Trust, Birmingham, England, United Kingdom
raw_author_name: Lydia Champezou
raw_affiliation_strings: European Organisation for Research and Treatment of Cancer, Brussels, Brussels Hoofdstedelijk Gewest, Belgium
raw_author_name: Sylvie Bonvalot
raw_affiliation_strings: Institut Curie, Paris, Ile-de-France, France
raw_author_name: Carol J.J. Swallow
raw_affiliation_strings: Princess Margaret Cancer Centre, University Health Network and Mount Sinai Hospital, Toronto, ON, Canada
raw_author_name: Dirk Strauss
raw_affiliation_strings: The Royal Marsden Hospital NHS Foundation Trust, London, England, United Kingdom
raw_author_name: Chandrajit P. Raut
raw_affiliation_strings: Brigham and Women's Hospital, Boston, MA
raw_author_name: W.J.J. van Houdt
raw_affiliation_strings: The Netherlands Cancer Institute, Amsterdam, Noord-Holland, Netherlands
raw_author_name: Sandrine Marreaud
raw_affiliation_strings: European Organisation for Research and Treatment of Cancer, Brussels, Brussels Hoofdstedelijk Gewest, Belgium
raw_author_name: Rick L. Haas
raw_affiliation_strings: The Netherlands Cancer Institute, Amsterdam, Noord-Holland, Netherlands
raw_author_name: Felix B.B. Oppong
raw_affiliation_strings: European Organisation for Research and Treatment of Cancer, Brussels, Brussels Hoofdstedelijk Gewest, Belgium
raw_author_name: Alessandro Gronchi
raw_affiliation_strings: Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Milano, Lombardia, Italy
raw_author_name: Samuel J. Ford
raw_affiliation_strings: University Hospitals Birmingham NHS Foundation Trust, Birmingham, England, United Kingdom